2-amino-9-B-D-arabinosyl-6-methoxy-9H-guanine (GW 506U; compound 506U) is highly active in patients with T-cell malignancies: Results of a phase I trial in pediatric and adult patients with refractory hematological malignancies.
Publication
, Journal Article
Kurtzberg, J; Keating, M; Moore, JO; Gandhi, V; Blaney, S; Gold, S; Ernst, T; HensleeDowney, J; Chang, A; Kisor, D; Plunkett, W; Mitchell, B
Published in: Blood
November 15, 1996
Duke Scholars
Published In
Blood
ISSN
0006-4971
Publication Date
November 15, 1996
Volume
88
Issue
10
Start / End Page
2666 / 2666
Publisher
W B SAUNDERS CO
Related Subject Headings
- Immunology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Kurtzberg, J., Keating, M., Moore, J. O., Gandhi, V., Blaney, S., Gold, S., … Mitchell, B. (1996). 2-amino-9-B-D-arabinosyl-6-methoxy-9H-guanine (GW 506U; compound 506U) is highly active in patients with T-cell malignancies: Results of a phase I trial in pediatric and adult patients with refractory hematological malignancies. Blood, 88(10), 2666–2666.
Kurtzberg, J., M. Keating, J. O. Moore, V. Gandhi, S. Blaney, S. Gold, T. Ernst, et al. “2-amino-9-B-D-arabinosyl-6-methoxy-9H-guanine (GW 506U; compound 506U) is highly active in patients with T-cell malignancies: Results of a phase I trial in pediatric and adult patients with refractory hematological malignancies.” Blood 88, no. 10 (November 15, 1996): 2666–2666.
Kurtzberg J, Keating M, Moore JO, Gandhi V, Blaney S, Gold S, et al. 2-amino-9-B-D-arabinosyl-6-methoxy-9H-guanine (GW 506U; compound 506U) is highly active in patients with T-cell malignancies: Results of a phase I trial in pediatric and adult patients with refractory hematological malignancies. Blood. 1996 Nov 15;88(10):2666–2666.
Kurtzberg, J., et al. “2-amino-9-B-D-arabinosyl-6-methoxy-9H-guanine (GW 506U; compound 506U) is highly active in patients with T-cell malignancies: Results of a phase I trial in pediatric and adult patients with refractory hematological malignancies.” Blood, vol. 88, no. 10, W B SAUNDERS CO, Nov. 1996, pp. 2666–2666.
Kurtzberg J, Keating M, Moore JO, Gandhi V, Blaney S, Gold S, Ernst T, HensleeDowney J, Chang A, Kisor D, Plunkett W, Mitchell B. 2-amino-9-B-D-arabinosyl-6-methoxy-9H-guanine (GW 506U; compound 506U) is highly active in patients with T-cell malignancies: Results of a phase I trial in pediatric and adult patients with refractory hematological malignancies. Blood. W B SAUNDERS CO; 1996 Nov 15;88(10):2666–2666.
Published In
Blood
ISSN
0006-4971
Publication Date
November 15, 1996
Volume
88
Issue
10
Start / End Page
2666 / 2666
Publisher
W B SAUNDERS CO
Related Subject Headings
- Immunology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology